Trials / Completed
CompletedNCT05567874
Nosocomial COVID-19 Infections in Patients Hospitalized at the Metz-Thionville Regional Hospital in 2021
Proportion of Nosocomial COVID-19 Infections in Patients Hospitalized at the Metz-Thionville Regional Hospital in 2021
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 216 (actual)
- Sponsor
- Centre Hospitalier Régional Metz-Thionville · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The rate of nosocomial SARS-CoV2 infections found in the different studies since the beginning of the pandemic is very variable (\<1% in hospitals in the USA to about 20% in a British hospital). Mortality related to these nosocomial SARS-CoV2 infections is higher than in the general population. The risk factors identified for this nosocomial acquisition are multiple. We were confronted with nosocomial acquisitions and cluster situations in the services, without exhaustive data to measure these phenomena, and we lacked data to consider areas for improvement. The objectives of this study are to determine the proportion of nosocomial SARS COV 2 infections in the total number of patients hospitalized with a Covid-19 infection at the CHR Metz-Thionville in 2021, and to describe the characteristics of this population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Nosocomial SARS-COV 2 Infection proportion | Proportion of Nosocomial SARS-COV 2 Infections in Patients Hospitalized at the Metz-Thionville Regional Hospital in 2021 |
Timeline
- Start date
- 2022-01-03
- Primary completion
- 2022-03-31
- Completion
- 2022-08-31
- First posted
- 2022-10-05
- Last updated
- 2023-05-06
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05567874. Inclusion in this directory is not an endorsement.